The Clinical and Economic Impact of LEMS in SCLC Care

A medical expert discusses how disparities in health care access affect the management and outcomes of Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer, how health care providers can quantify the economic burden of LEMS on both patients and health care systems, the role of patient-reported outcomes in providing deeper insights into the clinical and economic burden of LEMS, and how health systems can utilize real-world data to better understand the indirect costs of LEMS.

EP: 1.LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

EP: 2.Strategies to Alleviate the Clinical and Economic Burden of LEMS

Now Viewing

EP: 3.The Clinical and Economic Impact of LEMS in SCLC Care

Video content above is prompted by the following:

1. How do disparities in health care access affect the management and outcomes of Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer?
2. How can health care providers quantify the economic burden of LEMS on both patients and health care systems?
3. In what ways can patient-reported outcomes provide deeper insights into the clinical and economic burden of LEMS?
4. How can health systems utilize real-world data to better understand the indirect costs of LEMS?

Related Videos